Your browser doesn't support javascript.
loading
NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model.
Barsoumian, Hampartsoum B; He, Kewen; Hsu, Ethan; Bertolet, Genevieve; Sezen, Duygu; Hu, Yun; Riad, Thomas S; Cortez, Maria Angelica; Welsh, James W.
Affiliation
  • Barsoumian HB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA.
  • He K; Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China.
  • Hsu E; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA.
  • Bertolet G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA.
  • Sezen D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA.
  • Hu Y; Department of Radiation Oncology, Koç University School of Medicine, Istanbul, Turkey.
  • Riad TS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA.
  • Cortez MA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA.
  • Welsh JW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA.
Cancer Immunol Immunother ; 72(9): 3003-3012, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37289257

Full text: 1 Database: MEDLINE Main subject: NLR Family, Pyrin Domain-Containing 3 Protein / Adenocarcinoma of Lung Limits: Animals Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: NLR Family, Pyrin Domain-Containing 3 Protein / Adenocarcinoma of Lung Limits: Animals Language: En Year: 2023 Type: Article